Drug Utilization Evaluation Study of Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting: A Cross-Sectional Study
Sponsor study identifier
observational
151
1 country
1
Study Start
September 1, 2021
Actual (reported)Primary Completion
February 28, 2022
Actual (reported)Study Completion
March 1, 2022
Actual (reported)Background: Ciprofloxacin is a fluoroquinolone that is commonly used to treat a variety of diseases. Ciprofloxacin resistance is rising, resulting in suboptimal patient care. The goal of this study was to evaluate ciprofloxacin use in the community in terms of acceptable prescription, dose, frequency, and duration of use. Methods: A cross-sectional research was done in Egyptian community pharmacies by community pharmacists. Patients who were administered oral ciprofloxacin during the research period were included.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 1, 2022
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 1, 2021
Actual (reported)February 28, 2022
Actual (reported)March 1, 2022
Actual (reported)June 13, 2023
Actual (reported)June 23, 2023
Actual (reported)Indications
Appropriate Indications of ciprofloxacin (frequency )
6 months
ciprofloxacin prescription (frequency )
Number of appropriate ciprofloxacin prescription
6 months
adverse events
adverse events occured during ciprofloxacin therapy (frequency )
6 months
151 record of Ciprofloxacin
A total of 151 patients' record indicated for ciprofloxacin were included in the study.
Rehab Hussein Werida
Damanhūr, Elbehairah, 31527, Egypt
Goldman MP. Ciprofloxacin drug utilization review and prospective drug use evaluation. DICP. 1990 Jan;24(1):82-6. doi: 10.1177/106002809002400115.
Davis R, Markham A, Balfour JA. Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability. Drugs. 1996 Jun;51(6):1019-74. doi: 10.2165/00003495-199651060-00010.
Rehab H Werida, Ass. Prof.
Damanhour University
151 participants (actual enrollment reported by the registry).
First Submitted
June 13, 2023
First Posted
June 23, 2023
Study Start
September 1, 2021
Actual (reported)Pharmacokinetics of Ciprofloxacin in Pediatric Patients
Contact the study team to confirm eligibility.
Primary Completion
February 28, 2022
Actual (reported)Study Completion
March 1, 2022
Actual (reported)Last Updated
June 23, 2023
Record last verified: 2023-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: